Real-time enrollment status for this solid tumor malignancies clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 8:45 AM UTC
| NCT Number | NCT06136884 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor Malignancies |
| Phase | PHASE1 |
| Target Enrollment | 86 participants |
| Active Locations | 6 sites in the US |
| Sponsor | A2A Pharmaceuticals Inc. |
| Last Updated on CT.gov | August 17, 2026 (1 week ago) |
As of August 27, 2026: Clinical trial NCT06136884 is currently recruiting participants. This phase1 study for solid tumor malignancies is actively seeking new participants at 6 locations across the United States. The study is sponsored by A2A Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06136884 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06136884 was last updated 1 week ago (August 17, 2026). HelloStudys verifies this status automatically.